These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27178522)

  • 1. Time trends in recurrence of juvenile nasopharyngeal angiofibroma: Experience of the past 4 decades.
    Mishra A; Mishra SC
    Am J Otolaryngol; 2016; 37(3):265-71. PubMed ID: 27178522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile nasopharyngeal angiofibroma: a single institution study.
    Mistry RC; Qureshi SS; Gupta S; Gupta S
    Indian J Cancer; 2005; 42(1):35-9. PubMed ID: 15805690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile nasopharyngeal angiofibroma: a single centre's 11-year experience.
    Pamuk AE; Özer S; Süslü AE; Akgöz A; Önerci M
    J Laryngol Otol; 2018 Nov; 132(11):978-983. PubMed ID: 30345941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Embolization to Improve the Surgical Management and Outcome of Juvenile Nasopharyngeal Angiofibroma (JNA) in a Single Center: 10-Year Experience.
    Lutz J; Holtmannspötter M; Flatz W; Meier-Bender A; Berghaus A; Brückmann H; Zengel P
    Clin Neuroradiol; 2016 Dec; 26(4):405-413. PubMed ID: 25630469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile and multimodality approach in the management of juvenile nasopharyngeal angiofibroma.
    Rao BN; Shewalkar BK
    Indian J Cancer; 2000 Dec; 37(4):133-9. PubMed ID: 12018564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile nasopharyngeal angiofibroma: long-term results in preoperative embolized and non-embolized patients.
    Petruson K; Rodriguez-Catarino M; Petruson B; Finizia C
    Acta Otolaryngol; 2002 Jan; 122(1):96-100. PubMed ID: 11876606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive Treatment in Juvenile Nasopharyngeal Angiofibroma: How Should We Approach Recurrence?
    Scholfield DW; Brundler MA; McDermott AL; Mussai F; Kearns P
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):235-9. PubMed ID: 26907644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiofibroma juvenile in the clinical material of Department of Otolaryngology in Poznan in the years 1977-2000 ].
    Szmeja Z; Nowak K; Kaczmarek J
    Otolaryngol Pol; 2003; 57(2):199-202. PubMed ID: 12894423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile nasopharyngeal angiofibroma: clinical factors associated with recurrence, and proposal of a staging system.
    Carrillo JF; Maldonado F; Albores O; Ramírez-Ortega MC; Oñate-Ocaña LF
    J Surg Oncol; 2008 Aug; 98(2):75-80. PubMed ID: 18623038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile nasopharyngeal angiofibroma: clinical factors associated with recurrence and proposal of a staging system.
    Dabholkar JP
    J Surg Oncol; 2008 Aug; 98(2):73. PubMed ID: 18623035
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiofibroma: an outcome review of conventional surgical approaches.
    Hosseini SM; Borghei P; Borghei SH; Ashtiani MT; Shirkhoda A
    Eur Arch Otorhinolaryngol; 2005 Oct; 262(10):807-12. PubMed ID: 15739087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing trends in the incidence of juvenile nasopharyngeal angiofibroma: seven decades of experience at King George's Medical University, Lucknow, India.
    Mishra A; Mishra SC
    J Laryngol Otol; 2016 Apr; 130(4):363-8. PubMed ID: 26864451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evolution in the treatment of juvenile nasopharyngeal angiofibroma].
    Llorente JL; López F; Suárez V; Costales M; Suárez C
    Acta Otorrinolaringol Esp; 2011; 62(4):279-86. PubMed ID: 21474108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile nasopharyngeal angiofibroma: vascular determinates for operative complications and tumor recurrence.
    Chan KH; Gao D; Fernandez PG; Kingdom TT; Kumpe DA
    Laryngoscope; 2014 Mar; 124(3):672-7. PubMed ID: 23929652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare complication of embolization in juvenile nasopharyngeal angiofibroma.
    Onerci M; Gumus K; Cil B; Eldem B
    Int J Pediatr Otorhinolaryngol; 2005 Mar; 69(3):423-8. PubMed ID: 15733605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transpalatal approach in juvenile nasopharyngeal angiofibroma].
    Unsal Tuna E; Karaca C; Kaymakçi M; Ozbek C; Ozdem C
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):7-12. PubMed ID: 17483604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of selective percutaneous embolization for the treatment of intractable posterior epistaxis and juvenile nasopharyngeal angiofibroma (JNA).
    Santaolalla F; Araluce I; Zabala A; López A; Garay M; Sanchez JM
    Acta Otolaryngol; 2009 Dec; 129(12):1456-62. PubMed ID: 19922097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile nasopharyngeal angiofibroma.
    Tewfik TL; Tan AK; al Noury K; Chowdhury K; Tampieri D; Raymond J; Vuong T
    J Otolaryngol; 1999 Jun; 28(3):145-51. PubMed ID: 10410346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of risk factors associated with recurrence of nasopharyngeal angiofibroma.
    Sun XC; Wang DH; Yu HP; Wang F; Wang W; Jiang JJ
    J Otolaryngol Head Neck Surg; 2010 Feb; 39(1):56-61. PubMed ID: 20122346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic approach for excision of juvenile nasopharyngeal angiofibroma: complications and outcomes.
    Ardehali MM; Samimi Ardestani SH; Yazdani N; Goodarzi H; Bastaninejad S
    Am J Otolaryngol; 2010; 31(5):343-9. PubMed ID: 20015778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.